2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study
Authors:
- A. StopeckASA. Stopeck
- J.J. BodyJBJ.J. Body
- Y. FujiwaraYFY. Fujiwara
- A. LiptonALA. Lipton
- G.G. StegerGSG.G. Steger
- M. ViniegraMVM. Viniegra
- M. FanMFM. Fan
- A. BraunABA. Braun
- R. DanseyRDR. Dansey
- S. JunSJS. Jun
- 1 September 2009
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 7 (3) , 2-3